Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. / Vestergaard, Henrik; Bjørbaek, C.; Hansen, T.; Larsen, F. S.; Granner, D. K.; Pedersen, O.

In: The Journal of Clinical Investigation, Vol. 96, No. 6, 1995, p. 2639-45.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Vestergaard, H, Bjørbaek, C, Hansen, T, Larsen, FS, Granner, DK & Pedersen, O 1995, 'Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients', The Journal of Clinical Investigation, vol. 96, no. 6, pp. 2639-45. https://doi.org/10.1172/JCI118329

APA

Vestergaard, H., Bjørbaek, C., Hansen, T., Larsen, F. S., Granner, D. K., & Pedersen, O. (1995). Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. The Journal of Clinical Investigation, 96(6), 2639-45. https://doi.org/10.1172/JCI118329

Vancouver

Vestergaard H, Bjørbaek C, Hansen T, Larsen FS, Granner DK, Pedersen O. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. The Journal of Clinical Investigation. 1995;96(6):2639-45. https://doi.org/10.1172/JCI118329

Author

Vestergaard, Henrik ; Bjørbaek, C. ; Hansen, T. ; Larsen, F. S. ; Granner, D. K. ; Pedersen, O. / Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. In: The Journal of Clinical Investigation. 1995 ; Vol. 96, No. 6. pp. 2639-45.

Bibtex

@article{32ded582d41b45f5b1848edf1938c917,
title = "Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients",
abstract = "After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.",
keywords = "Adult, Aged, Base Sequence, Blood Glucose, Case-Control Studies, DNA Primers, Diabetes Mellitus, Type 2, Fasting, Fatty Acids, Nonesterified, Female, Gene Expression, Glucose Clamp Technique, Glycogen Synthase, Hexokinase, Humans, Insulin, Insulin Resistance, Isoenzymes, Male, Middle Aged, Molecular Sequence Data, Muscle, Skeletal, Polymerase Chain Reaction, RNA, Messenger, Reference Values, Statistics, Nonparametric, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't",
author = "Henrik Vestergaard and C. Bj{\o}rbaek and T. Hansen and Larsen, {F. S.} and Granner, {D. K.} and O. Pedersen",
year = "1995",
doi = "10.1172/JCI118329",
language = "English",
volume = "96",
pages = "2639--45",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "American Society for Clinical Investigation",
number = "6",

}

RIS

TY - JOUR

T1 - Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients

AU - Vestergaard, Henrik

AU - Bjørbaek, C.

AU - Hansen, T.

AU - Larsen, F. S.

AU - Granner, D. K.

AU - Pedersen, O.

PY - 1995

Y1 - 1995

N2 - After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.

AB - After entering the muscle cell, glucose is immediately and irreversibly phosphorylated to glucose-6-phosphate by hexokinases (HK) I and II. Previous studies in rodents have shown that HKII may be the dominant HK in skeletal muscle. Reduced insulin-stimulated glucose uptake and reduced glucose-6-phosphate concentrations in muscle have been found in non-insulin-dependent diabetes mellitus (NIDDM) patients when examined during a hyperglycemic hyperinsulinemic clamp. These findings [correction of finding] are consistent with a defect in glucose transport and/or phosphorylation. In the present study comprising 29 NIDDM patients and 25 matched controls, we tested the hypothesis that HKII activity and gene expression are impaired in vastus lateralis muscle of NIDDM patients when examined in the fasting state. HKII activity in a supernatant of muscle extract accounted for 28 +/- 5% in NIDDM patients and 40 +/- 5% in controls (P = 0.08) of total muscle HK activity when measured at a glucose media of 0.11 mmol/liter and 31 +/- 4 and 47 +/- 7% (P = 0.02) when measured at 0.11 mmol/liter of glucose. HKII mRNA, HKII immunoreactive protein level, and HKII activity were significantly decreased in NIDDM patients (P < 0.0001, P = 0.03, and P = 0.02, respectively) together with significantly decreased glycogen synthase mRNA level and total glycogen synthase activity (P = 0.02 and P = 0.02, respectively). In the entire study population HKII activity estimated at 0.11 and 11.0 mM glucose was inversely correlated with fasting plasma glucose concentrations (r = -0.45, P = 0.004; r = -0.54, P < 0.0001, respectively) and fasting plasma nonesterified fatty acid concentrations (r = -0.46, P = 0.003; r = -0.37, P = 0.02, respectively). In conclusion, NIDDM patients are characterized by a reduced activity and a reduced gene expression of HKII in muscle which may be secondary to the metabolic peturbations. HKII contributes with about one-third of total HK activity in a supernatant of human vastus lateralis muscle.

KW - Adult

KW - Aged

KW - Base Sequence

KW - Blood Glucose

KW - Case-Control Studies

KW - DNA Primers

KW - Diabetes Mellitus, Type 2

KW - Fasting

KW - Fatty Acids, Nonesterified

KW - Female

KW - Gene Expression

KW - Glucose Clamp Technique

KW - Glycogen Synthase

KW - Hexokinase

KW - Humans

KW - Insulin

KW - Insulin Resistance

KW - Isoenzymes

KW - Male

KW - Middle Aged

KW - Molecular Sequence Data

KW - Muscle, Skeletal

KW - Polymerase Chain Reaction

KW - RNA, Messenger

KW - Reference Values

KW - Statistics, Nonparametric

KW - Comparative Study

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1172/JCI118329

DO - 10.1172/JCI118329

M3 - Journal article

C2 - 8675629

VL - 96

SP - 2639

EP - 2645

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -

ID: 174866704